nodes	percent_of_prediction	percent_of_DWPC	metapath
Forasartan—AGTR1—breast cancer	0.916	1	CbGaD
Forasartan—Tasosartan—AGTR2—breast cancer	0.00236	0.222	CrCbGaD
Forasartan—Valsartan—SLCO1B1—breast cancer	0.000883	0.0833	CrCbGaD
Forasartan—Irbesartan—JUN—breast cancer	0.000865	0.0816	CrCbGaD
Forasartan—Olmesartan—SLCO1B1—breast cancer	0.00086	0.0811	CrCbGaD
Forasartan—Tasosartan—AGTR1—breast cancer	0.000816	0.077	CrCbGaD
Forasartan—Valsartan—AGTR1—breast cancer	0.000708	0.0668	CrCbGaD
Forasartan—AGTR1—nipple—breast cancer	0.000704	0.224	CbGeAlD
Forasartan—Olmesartan—AGTR1—breast cancer	0.00069	0.0651	CrCbGaD
Forasartan—Irbesartan—AGTR1—breast cancer	0.000536	0.0506	CrCbGaD
Forasartan—Candesartan—AGTR1—breast cancer	0.000536	0.0506	CrCbGaD
Forasartan—AGTR1—epithelium—breast cancer	0.000474	0.151	CbGeAlD
Forasartan—Losartan—SLCO1B1—breast cancer	0.000431	0.0407	CrCbGaD
Forasartan—AGTR1—pituitary gland—breast cancer	0.000384	0.122	CbGeAlD
Forasartan—AGTR1—adipose tissue—breast cancer	0.000383	0.122	CbGeAlD
Forasartan—AGTR1—female reproductive system—breast cancer	0.000352	0.112	CbGeAlD
Forasartan—Losartan—AGTR1—breast cancer	0.000346	0.0326	CrCbGaD
Forasartan—AGTR1—adrenal gland—breast cancer	0.000343	0.109	CbGeAlD
Forasartan—AGTR1—endocrine gland—breast cancer	0.000298	0.0947	CbGeAlD
Forasartan—AGTR1—GPCRs, Class A Rhodopsin-like—EDNRB—breast cancer	0.000278	0.00399	CbGpPWpGaD
Forasartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—TNF—breast cancer	0.000264	0.0038	CbGpPWpGaD
Forasartan—AGTR1—Allograft Rejection—CXCL8—breast cancer	0.000263	0.00378	CbGpPWpGaD
Forasartan—AGTR1—G alpha (q) signalling events—ITPR1—breast cancer	0.000259	0.00372	CbGpPWpGaD
Forasartan—AGTR1—Allograft Rejection—IL1B—breast cancer	0.000253	0.00363	CbGpPWpGaD
Forasartan—AGTR1—Allograft Rejection—CASP3—breast cancer	0.000252	0.00362	CbGpPWpGaD
Forasartan—AGTR1—Allograft Rejection—IL2—breast cancer	0.000252	0.00362	CbGpPWpGaD
Forasartan—Candesartan—PTGS1—breast cancer	0.000249	0.0235	CrCbGaD
Forasartan—Irbesartan—PTGS1—breast cancer	0.000249	0.0235	CrCbGaD
Forasartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL2—breast cancer	0.000248	0.00357	CbGpPWpGaD
Forasartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—AGTR2—breast cancer	0.000248	0.00357	CbGpPWpGaD
Forasartan—AGTR1—GPCR ligand binding—CCL20—breast cancer	0.000247	0.00355	CbGpPWpGaD
Forasartan—AGTR1—GPCRs, Class A Rhodopsin-like—CXCR4—breast cancer	0.000246	0.00354	CbGpPWpGaD
Forasartan—AGTR1—GPCR downstream signaling—GPER1—breast cancer	0.000243	0.00349	CbGpPWpGaD
Forasartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—PIK3CA—breast cancer	0.000241	0.00346	CbGpPWpGaD
Forasartan—AGTR1—GPCR ligand binding—LPAR1—breast cancer	0.000239	0.00344	CbGpPWpGaD
Forasartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—EDNRB—breast cancer	0.000238	0.00342	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—STARD8—breast cancer	0.000238	0.00342	CbGpPWpGaD
Forasartan—AGTR1—GPCR downstream signaling—NMBR—breast cancer	0.000233	0.00335	CbGpPWpGaD
Forasartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—ITPR1—breast cancer	0.000231	0.00333	CbGpPWpGaD
Forasartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—breast cancer	0.00023	0.00331	CbGpPWpGaD
Forasartan—Tasosartan—CYP3A4—breast cancer	0.000222	0.0209	CrCbGaD
Forasartan—AGTR1—Signaling by GPCR—GPER1—breast cancer	0.00022	0.00317	CbGpPWpGaD
Forasartan—AGTR1—GPCR ligand binding—CNR2—breast cancer	0.00022	0.00316	CbGpPWpGaD
Forasartan—AGTR1—GPCR downstream signaling—PTGER1—breast cancer	0.000216	0.00311	CbGpPWpGaD
Forasartan—AGTR1—Allograft Rejection—VEGFA—breast cancer	0.000214	0.00307	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—NMBR—breast cancer	0.000211	0.00304	CbGpPWpGaD
Forasartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL12—breast cancer	0.000211	0.00304	CbGpPWpGaD
Forasartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCR4—breast cancer	0.000211	0.00304	CbGpPWpGaD
Forasartan—AGTR1—GPCR ligand binding—WNT1—breast cancer	0.000207	0.00297	CbGpPWpGaD
Forasartan—AGTR1—lymph node—breast cancer	0.000206	0.0655	CbGeAlD
Forasartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—AKT1—breast cancer	0.000197	0.00283	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—PTGER1—breast cancer	0.000197	0.00283	CbGpPWpGaD
Forasartan—AGTR1—Allograft Rejection—TGFB1—breast cancer	0.000196	0.00282	CbGpPWpGaD
Forasartan—AGTR1—GPCR downstream signaling—CXCL3—breast cancer	0.000193	0.00277	CbGpPWpGaD
Forasartan—AGTR1—GPCR downstream signaling—PDE2A—breast cancer	0.000193	0.00277	CbGpPWpGaD
Forasartan—AGTR1—GPCR downstream signaling—CCL27—breast cancer	0.000193	0.00277	CbGpPWpGaD
Forasartan—AGTR1—GPCR ligand binding—CXCL2—breast cancer	0.000189	0.00272	CbGpPWpGaD
Forasartan—AGTR1—GPCR ligand binding—AGTR2—breast cancer	0.000189	0.00272	CbGpPWpGaD
Forasartan—AGTR1—GPCR ligand binding—PTHLH—breast cancer	0.000187	0.00269	CbGpPWpGaD
Forasartan—AGTR1—Allograft Rejection—TNF—breast cancer	0.000183	0.00263	CbGpPWpGaD
Forasartan—AGTR1—GPCR ligand binding—EDNRB—breast cancer	0.000181	0.0026	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—WNT10B—breast cancer	0.00018	0.00258	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—CCL27—breast cancer	0.000175	0.00252	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—CXCL3—breast cancer	0.000175	0.00252	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—PDE2A—breast cancer	0.000175	0.00252	CbGpPWpGaD
Forasartan—Irbesartan—CYP2D6—breast cancer	0.00017	0.016	CrCbGaD
Forasartan—Valsartan—ALB—breast cancer	0.000168	0.0158	CrCbGaD
Forasartan—AGTR1—GPCR ligand binding—CALCA—breast cancer	0.000165	0.00237	CbGpPWpGaD
Forasartan—AGTR1—GPCR ligand binding—CXCL12—breast cancer	0.000161	0.00231	CbGpPWpGaD
Forasartan—AGTR1—GPCR ligand binding—CXCR4—breast cancer	0.000161	0.00231	CbGpPWpGaD
Forasartan—Irbesartan—CYP3A4—breast cancer	0.000146	0.0137	CrCbGaD
Forasartan—AGTR1—GPCR downstream signaling—RGS2—breast cancer	0.000141	0.00203	CbGpPWpGaD
Forasartan—AGTR1—GPCR downstream signaling—CCL20—breast cancer	0.000139	0.002	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—CCDC88C—breast cancer	0.000137	0.00196	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—LGR6—breast cancer	0.000137	0.00196	CbGpPWpGaD
Forasartan—AGTR1—GPCR downstream signaling—LPAR1—breast cancer	0.000135	0.00194	CbGpPWpGaD
Forasartan—AGTR1—Peptide ligand-binding receptors—CXCL8—breast cancer	0.00013	0.00188	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—GPER1—breast cancer	0.00013	0.00187	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—SFRP1—breast cancer	0.00013	0.00187	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—RGS2—breast cancer	0.000128	0.00184	CbGpPWpGaD
Forasartan—AGTR1—GPCR downstream signaling—PDE4D—breast cancer	0.000128	0.00183	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—CCL20—breast cancer	0.000127	0.00182	CbGpPWpGaD
Forasartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—breast cancer	0.000126	0.00181	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—NMBR—breast cancer	0.000125	0.0018	CbGpPWpGaD
Forasartan—AGTR1—GPCR downstream signaling—CNR2—breast cancer	0.000124	0.00179	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—LPAR1—breast cancer	0.000123	0.00176	CbGpPWpGaD
Forasartan—Candesartan—ABCB1—breast cancer	0.000121	0.0114	CrCbGaD
Forasartan—AGTR1—Signaling Pathways—HEYL—breast cancer	0.000116	0.00167	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—CUL5—breast cancer	0.000116	0.00167	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—PTGER1—breast cancer	0.000116	0.00167	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—PDE4D—breast cancer	0.000116	0.00167	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—CNR2—breast cancer	0.000113	0.00162	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—RSPO3—breast cancer	0.000109	0.00157	CbGpPWpGaD
Forasartan—AGTR1—GPCR downstream signaling—CXCL2—breast cancer	0.000107	0.00154	CbGpPWpGaD
Forasartan—AGTR1—GPCR downstream signaling—AGTR2—breast cancer	0.000107	0.00154	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—WNT10B—breast cancer	0.000106	0.00153	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—WWOX—breast cancer	0.000106	0.00153	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—WNT1—breast cancer	0.000106	0.00153	CbGpPWpGaD
Forasartan—AGTR1—GPCR downstream signaling—PTHLH—breast cancer	0.000106	0.00152	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—CCL27—breast cancer	0.000103	0.00149	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—PDE2A—breast cancer	0.000103	0.00149	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—INHBB—breast cancer	0.000103	0.00149	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—CXCL3—breast cancer	0.000103	0.00149	CbGpPWpGaD
Forasartan—AGTR1—GPCR downstream signaling—EDNRB—breast cancer	0.000102	0.00147	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—DLL4—breast cancer	9.87e-05	0.00142	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—BMPR2—breast cancer	9.87e-05	0.00142	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—AGTR2—breast cancer	9.71e-05	0.0014	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—CXCL2—breast cancer	9.71e-05	0.0014	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—PTHLH—breast cancer	9.6e-05	0.00138	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—CDH5—breast cancer	9.46e-05	0.00136	CbGpPWpGaD
Forasartan—Losartan—CYP3A4—breast cancer	9.38e-05	0.00885	CrCbGaD
Forasartan—AGTR1—GPCR downstream signaling—CALCA—breast cancer	9.3e-05	0.00134	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—EDNRB—breast cancer	9.3e-05	0.00134	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—SFRP2—breast cancer	9.28e-05	0.00133	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—PRLR—breast cancer	9.11e-05	0.00131	CbGpPWpGaD
Forasartan—AGTR1—GPCR downstream signaling—CXCR4—breast cancer	9.09e-05	0.00131	CbGpPWpGaD
Forasartan—AGTR1—GPCR downstream signaling—CXCL12—breast cancer	9.09e-05	0.00131	CbGpPWpGaD
Forasartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—breast cancer	9.08e-05	0.00131	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—GLI2—breast cancer	8.8e-05	0.00126	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—VCP—breast cancer	8.8e-05	0.00126	CbGpPWpGaD
Forasartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—breast cancer	8.75e-05	0.00126	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—LEPR—breast cancer	8.66e-05	0.00124	CbGpPWpGaD
Forasartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—breast cancer	8.64e-05	0.00124	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—CALCA—breast cancer	8.45e-05	0.00121	CbGpPWpGaD
Forasartan—AGTR1—G alpha (q) signalling events—PIK3CA—breast cancer	8.38e-05	0.00121	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—CXCL12—breast cancer	8.25e-05	0.00119	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—CXCR4—breast cancer	8.25e-05	0.00119	CbGpPWpGaD
Forasartan—Losartan—ALB—breast cancer	8.18e-05	0.00772	CrCbGaD
Forasartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—breast cancer	8.16e-05	0.00117	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—ARHGDIA—breast cancer	8.05e-05	0.00116	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—FST—breast cancer	7.84e-05	0.00113	CbGpPWpGaD
Forasartan—Losartan—ABCB1—breast cancer	7.81e-05	0.00737	CrCbGaD
Forasartan—AGTR1—Signaling Pathways—HEY2—breast cancer	7.75e-05	0.00111	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—RPS6KB2—breast cancer	7.65e-05	0.0011	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—RGS2—breast cancer	7.57e-05	0.00109	CbGpPWpGaD
Forasartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—breast cancer	7.5e-05	0.00108	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—CCL20—breast cancer	7.48e-05	0.00108	CbGpPWpGaD
Forasartan—AGTR1—GPCR downstream signaling—ITPR1—breast cancer	7.38e-05	0.00106	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—LPAR1—breast cancer	7.25e-05	0.00104	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—TLE3—breast cancer	7.25e-05	0.00104	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—HEY1—breast cancer	7.17e-05	0.00103	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—DLL1—breast cancer	7.03e-05	0.00101	CbGpPWpGaD
Forasartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—breast cancer	6.94e-05	0.000997	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—HIST1H2BC—breast cancer	6.9e-05	0.000993	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—HIST1H2BK—breast cancer	6.9e-05	0.000993	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—GRB7—breast cancer	6.84e-05	0.000984	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—PDE4D—breast cancer	6.84e-05	0.000984	CbGpPWpGaD
Forasartan—AGTR1—GPCR downstream signaling—CSF2—breast cancer	6.81e-05	0.000979	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—TAB2—breast cancer	6.72e-05	0.000967	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—ITPR1—breast cancer	6.7e-05	0.000963	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—CNR2—breast cancer	6.67e-05	0.000959	CbGpPWpGaD
Forasartan—AGTR1—GPCR ligand binding—CXCL8—breast cancer	6.66e-05	0.000958	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—MMP3—breast cancer	6.65e-05	0.000956	CbGpPWpGaD
Forasartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—breast cancer	6.64e-05	0.000954	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—DKK1—breast cancer	6.51e-05	0.000936	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—VEGFC—breast cancer	6.46e-05	0.000928	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—JAG2—breast cancer	6.36e-05	0.000915	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—WNT1—breast cancer	6.27e-05	0.000901	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—PLA2G4A—breast cancer	6.25e-05	0.000899	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—CSF2—breast cancer	6.18e-05	0.000889	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—NOTCH4—breast cancer	5.94e-05	0.000854	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—GZMB—breast cancer	5.91e-05	0.000849	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—CXCL2—breast cancer	5.73e-05	0.000824	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—AGTR2—breast cancer	5.73e-05	0.000824	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—PTHLH—breast cancer	5.67e-05	0.000815	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—BMP2—breast cancer	5.67e-05	0.000815	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—EDNRB—breast cancer	5.49e-05	0.000789	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—PGR—breast cancer	5.44e-05	0.000781	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—THBS1—breast cancer	5.41e-05	0.000778	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—FLT1—breast cancer	5.16e-05	0.000742	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—FGF3—breast cancer	5.14e-05	0.000739	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—SQSTM1—breast cancer	5.14e-05	0.000739	CbGpPWpGaD
Forasartan—AGTR1—GPCR downstream signaling—PIK3CG—breast cancer	5.11e-05	0.000735	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—JAG1—breast cancer	5.07e-05	0.00073	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—PARP1—breast cancer	5.05e-05	0.000727	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—NOTCH3—breast cancer	5.05e-05	0.000727	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—CALCA—breast cancer	4.99e-05	0.000718	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—RPS6—breast cancer	4.93e-05	0.000709	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—FGF4—breast cancer	4.89e-05	0.000704	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—CXCL12—breast cancer	4.88e-05	0.000701	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—CXCR4—breast cancer	4.88e-05	0.000701	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—PAK1—breast cancer	4.79e-05	0.000688	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—TCF7L2—breast cancer	4.7e-05	0.000676	CbGpPWpGaD
Forasartan—AGTR1—GPCR downstream signaling—AKT2—breast cancer	4.68e-05	0.000673	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—PIK3CG—breast cancer	4.64e-05	0.000668	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—HSP90AA1—breast cancer	4.53e-05	0.000652	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—NOTCH2—breast cancer	4.53e-05	0.000652	CbGpPWpGaD
Forasartan—AGTR1—GPCR downstream signaling—PIK3CD—breast cancer	4.5e-05	0.000646	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—PRL—breast cancer	4.41e-05	0.000634	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—ADAM10—breast cancer	4.35e-05	0.000625	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—STK11—breast cancer	4.35e-05	0.000625	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—PLG—breast cancer	4.3e-05	0.000618	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—AKT2—breast cancer	4.25e-05	0.000611	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—FGF10—breast cancer	4.23e-05	0.000608	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—PIK3CD—breast cancer	4.08e-05	0.000587	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—PDGFA—breast cancer	4.08e-05	0.000586	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—TGFBR2—breast cancer	4.02e-05	0.000578	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—ITPR1—breast cancer	3.96e-05	0.000569	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—STAT5A—breast cancer	3.93e-05	0.000565	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—ERBB4—breast cancer	3.93e-05	0.000565	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—MMP3—breast cancer	3.93e-05	0.000565	CbGpPWpGaD
Forasartan—AGTR1—GPCR downstream signaling—PIK3CB—breast cancer	3.92e-05	0.000563	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—SMAD4—breast cancer	3.81e-05	0.000547	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—IGF1R—breast cancer	3.78e-05	0.000544	CbGpPWpGaD
Forasartan—AGTR1—GPCR downstream signaling—CXCL8—breast cancer	3.77e-05	0.000541	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—HES1—breast cancer	3.72e-05	0.000534	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—PLA2G4A—breast cancer	3.69e-05	0.000531	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—NCOR1—breast cancer	3.69e-05	0.000531	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—FGF1—breast cancer	3.65e-05	0.000525	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—CSF2—breast cancer	3.65e-05	0.000525	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—RAF1—breast cancer	3.65e-05	0.000524	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—NRG1—breast cancer	3.63e-05	0.000521	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—H2AFX—breast cancer	3.6e-05	0.000518	CbGpPWpGaD
Forasartan—AGTR1—GPCR downstream signaling—IL2—breast cancer	3.6e-05	0.000517	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—E2F1—breast cancer	3.58e-05	0.000514	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—PIK3CB—breast cancer	3.56e-05	0.000512	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—SPP1—breast cancer	3.44e-05	0.000494	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—CXCL8—breast cancer	3.42e-05	0.000492	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—ERBB3—breast cancer	3.4e-05	0.000488	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—FGFR2—breast cancer	3.39e-05	0.000488	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—IL2—breast cancer	3.27e-05	0.00047	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—TERT—breast cancer	3.26e-05	0.000468	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—FGFR1—breast cancer	3.16e-05	0.000455	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—HIF1A—breast cancer	3.11e-05	0.000448	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—LEP—breast cancer	3.04e-05	0.000437	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—CAV1—breast cancer	3.01e-05	0.000433	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—KDR—breast cancer	2.98e-05	0.000428	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—ESR1—breast cancer	2.9e-05	0.000417	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—FN1—breast cancer	2.87e-05	0.000412	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—NFKBIA—breast cancer	2.83e-05	0.000407	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—NOTCH1—breast cancer	2.81e-05	0.000403	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—APC—breast cancer	2.74e-05	0.000394	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—PIK3CG—breast cancer	2.74e-05	0.000394	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—KIT—breast cancer	2.74e-05	0.000394	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—EGF—breast cancer	2.71e-05	0.00039	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—MAPK3—breast cancer	2.63e-05	0.000378	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—BRAF—breast cancer	2.58e-05	0.000371	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—IGF1—breast cancer	2.51e-05	0.000361	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—AKT2—breast cancer	2.51e-05	0.000361	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—EGFR—breast cancer	2.5e-05	0.000359	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—PIK3CD—breast cancer	2.41e-05	0.000347	CbGpPWpGaD
Forasartan—AGTR1—GPCR downstream signaling—PIK3CA—breast cancer	2.39e-05	0.000343	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—SERPINE1—breast cancer	2.39e-05	0.000343	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—KRAS—breast cancer	2.36e-05	0.000339	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—NOS3—breast cancer	2.28e-05	0.000327	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—PIK3CA—breast cancer	2.17e-05	0.000312	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—MDM2—breast cancer	2.16e-05	0.000311	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—RAF1—breast cancer	2.15e-05	0.00031	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—RELA—breast cancer	2.14e-05	0.000308	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—ERBB2—breast cancer	2.13e-05	0.000306	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—MTOR—breast cancer	2.1e-05	0.000302	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—PIK3CB—breast cancer	2.1e-05	0.000302	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—CXCL8—breast cancer	2.02e-05	0.00029	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—HRAS—breast cancer	2.01e-05	0.000289	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—CDKN1B—breast cancer	1.97e-05	0.000284	CbGpPWpGaD
Forasartan—AGTR1—GPCR downstream signaling—AKT1—breast cancer	1.95e-05	0.000281	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—CASP3—breast cancer	1.93e-05	0.000278	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—IL2—breast cancer	1.93e-05	0.000278	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—IL6—breast cancer	1.92e-05	0.000276	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—CCND1—breast cancer	1.88e-05	0.000271	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—JUN—breast cancer	1.88e-05	0.00027	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—CTNNB1—breast cancer	1.86e-05	0.000268	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—MMP9—breast cancer	1.83e-05	0.000263	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—CDKN1A—breast cancer	1.82e-05	0.000262	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—PTEN—breast cancer	1.82e-05	0.000261	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—MAPK8—breast cancer	1.78e-05	0.000255	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—AKT1—breast cancer	1.77e-05	0.000255	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—SRC—breast cancer	1.68e-05	0.000242	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—VEGFA—breast cancer	1.64e-05	0.000236	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—STAT3—breast cancer	1.62e-05	0.000234	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—MAPK3—breast cancer	1.55e-05	0.000223	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—MYC—breast cancer	1.51e-05	0.000217	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—TGFB1—breast cancer	1.51e-05	0.000217	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—EGFR—breast cancer	1.48e-05	0.000212	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—KRAS—breast cancer	1.39e-05	0.000201	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—PIK3CA—breast cancer	1.28e-05	0.000184	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—TP53—breast cancer	1.24e-05	0.000178	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—HRAS—breast cancer	1.19e-05	0.00017	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—IL6—breast cancer	1.13e-05	0.000163	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—AKT1—breast cancer	1.05e-05	0.000151	CbGpPWpGaD
